Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy

Prostate cancer (PCa) is a prevalent malignancy with increasing incidence in middle-aged and older men. Despite various treatment options, advanced metastatic PCa remains challenging with poor prognosis and limited effective therapies. Nanomedicine, with its targeted drug delivery capabilities, has...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Mingze, Cao, Yu, Chi, Changliang, Zhao, Jiang, Chong, Eunice, Chin, Ke Xin Casey, Tan, Nicole Zian Vi, Dmitry, Korolev, Yang, Guodong, Yang, Xinyi, Hu, Kebang, Enikeev, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545965/
https://www.ncbi.nlm.nih.gov/pubmed/37795091
http://dx.doi.org/10.3389/fimmu.2023.1265751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545965/
https://www.ncbi.nlm.nih.gov/pubmed/37795091
http://dx.doi.org/10.3389/fimmu.2023.1265751

Ejemplares similares